Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

No significant differences in HbA1c or 25-hydroxyvitamin D levels were observed between MD and Control groups or across multiple subgroups, irrespective of supplementation status (online Supplementary Tables 1 and 2).

Source: HBA1c and 25-hydroxyvitamin D. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

MD participants were eligible to participate if they had received a diagnosis of MD (any condition on the MD spectrum as defined by Muscular Dystrophy UK)() were aged between 18 and 80 years (chronological age), had any level of functional ability and were regularly attending the centre for physiotherapy, defined as minimum 1 visit per month.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Nutritional status is linked to muscle strength and perceived function in adults with muscular dystrophy: evidence for targeted nutritional interventions

Study design awaiting verification · The British Journal of Nutrition · 2026

Original publication title

Nutritional status is linked to muscle strength and perceived function in adults with muscular dystrophy: evidence for targeted nutritional interventions

Meg Leaver; Christopher I. Morse; Paul Orme; Orla Flannery; Petra Kolic; Nathan Hodson

© The Author(s) 2025

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Muscular dystrophy (MD) encompasses inherited myopathies characterised by progressive skeletal and cardiac muscle degeneration, chronic inflammation and metabolic dysfunction. While emerging therapies show pre-clinical promise, few reach clinical translation, highlighting the need for supportive interventions to improve function and quality of life (QoL). Nutritional strategies may offer such benefits; however, limited data exist characterising diet in MD or associations with functional outcomes. This study assessed diet, nutritional status and associations with muscle strength, function and QoL in MD adults. Adults with MD (n 39; FSHD = 8, LGMD = 9 and Other = 22) and matched Controls (n 17) completed two 3-d food records, strength/function assessments and QoL questionnaires.

Between-group differences were analysed using t tests or Mann: Whitney U and associations using Pearson’s r or Spearman’s Rho (P < 0·05). Compared with controls, individuals with MD consumed more energy (89 % v. 35 % exceeded RDI, P = 0·023), but less carbohydrate (: 21 %, P = 0·013), sugar (: 31 %, P = 0·004), protein (: 15 %), BCAA (: 31 %, P = 0·049) and vitamin C (: 43 %, P = 0·009). MD participants demonstrated reduced muscle thickness, strength, function and reported lower QoL and physical capacity (all P < 0·05).

Protein intake positively correlated with strength and function (P < 0·05); branched-chain amino acids intake was associated with lean mass (r = 0·442, P = 0·02) and strength (r = 0·372, P = 0·036). Findings indicate adults with MD consume excess energy but insufficient protein and micronutrients, supporting the need for adult MD-specific dietary guidance to optimise musculoskeletal health and QoL.

Authors’ abstract

Muscular dystrophy (MD) encompasses inherited myopathies characterised by progressive skeletal and cardiac muscle degeneration, chronic inflammation and metabolic dysfunction. While emerging therapies show pre-clinical promise, few reach clinical translation, highlighting the need for supportive interventions to improve function and quality of life (QoL). Nutritional strategies may offer such benefits; however, limited data exist characterising diet in MD or associations with functional outcomes. This study assessed diet, nutritional status and associations with muscle strength, function and QoL in MD adults. Adults with MD (n 39; FSHD = 8, LGMD = 9 and Other = 22) and matched Controls (n 17) completed two 3-d food records, strength/function assessments and QoL questionnaires.

Between-group differences were analysed using t tests or Mann: Whitney U and associations using Pearson’s r or Spearman’s Rho (P < 0·05). Compared with controls, individuals with MD consumed more energy (89 % v. 35 % exceeded RDI, P = 0·023), but less carbohydrate (: 21 %, P = 0·013), sugar (: 31 %, P = 0·004), protein (: 15 %), BCAA (: 31 %, P = 0·049) and vitamin C (: 43 %, P = 0·009). MD participants demonstrated reduced muscle thickness, strength, function and reported lower QoL and physical capacity (all P < 0·05).

Protein intake positively correlated with strength and function (P < 0·05); branched-chain amino acids intake was associated with lean mass (r = 0·442, P = 0·02) and strength (r = 0·372, P = 0·036). Findings indicate adults with MD consume excess energy but insufficient protein and micronutrients, supporting the need for adult MD-specific dietary guidance to optimise musculoskeletal health and QoL.

Publication and source details

Original title: Nutritional status is linked to muscle strength and perceived function in adults with muscular dystrophy: evidence for targeted nutritional interventions

Meg Leaver; Christopher I. Morse; Paul Orme; Orla Flannery; Petra Kolic; Nathan Hodson

The British Journal of Nutrition · 2026

Corresponding author: Nathan Hodson; Email: n.w.hodson@bham.ac.uk © The Author(s) 20252025The Author(s)https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:54:14.230831+00:00

DOI: 10.1017/s0007114525106119 · PMC13315556